Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 751–752 | Cite as

ASO Author Reflections: Nodal Downstaging in Gastric Cancer

  • Naruhiko Ikoma
  • Brian D. BadgwellEmail author
ASO Author Reflections



The authors declare that they have no conflict of interest.


  1. 1.
    Ikoma N, Cormier JN, Feig B, et al. Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: analysis of the National Cancer Data Base, 2006–2014. Cancer. 2018;124(5):998–1007.CrossRefGoogle Scholar
  2. 2.
    Amin MB, Edge S, Greene F, et al. AJCC cancer staging manual. 8th ed. New York: Springer; 2017.CrossRefGoogle Scholar
  3. 3.
    Ikoma N, Estrella JS, Hofstetter W, et al. Nodal downstaging in gastric cancer patients: promising survival if ypn0 is achieved. Ann Surg Oncol. 2018;25:2012–7.CrossRefGoogle Scholar
  4. 4.
    Ikoma N, Blum M, Estrella JS, et al. Evaluation of the American Joint Committee on Cancer 8th edition staging system for gastric cancer patients after preoperative therapy. Gastric Cancer. 2017;21:74.CrossRefGoogle Scholar
  5. 5.
    Ikoma N, Hofstetter WL, Estrella JS, et al. The ypT category does not impact overall survival in node negative gastric cancer. J Surg Oncol. 2018;117(8):1721–8.CrossRefGoogle Scholar
  6. 6.
    Chia NY, Tan P. Molecular classification of gastric cancer. Ann Oncol. 2016;27(5):763–9.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Department of Surgical Oncology, Unit 1484The University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations